When the Teaching Material Is the Risk: The Governance Gap for AI-Generated Content in Medical Education

• by Boon-How Chew

• November 10, 2026

FDA approves first factor XIa stroke drug

In a 12,327-patient trial, asundexian cut recurrent ischemic stroke risk by 26% alongside antiplatelets.

• by Mouj Hijazi

• November 10, 2026

• 3 min

Dermatologist or AI? Patient Preferences in Skin Assessment

• by Grace Z. Armstrong, Chenan A. Huang, Anna K. Martino, Steven R. Feldman

• November 10, 2026

FDA flags vision loss risk with GLP-1 drugs

Analysis found higher rates of a rare optic nerve condition, prompting new warnings across the drug class.

• by Mouj Hijazi

• November 10, 2026

• 2 min